1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AURINIA PHARMACEUTICALS INC
Aurinia Pharmaceuticals Inc XNAS: AUPH

Aurinia Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for ...

Read More
14.61 0.66 (4.73%)
New 52W High in past week
2.9M
XNAS Volume
High vol.+gain this week

XNAS 07 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
High Financial Strength
83.3 / 100
Valuation Score
Mid Valuation
41.3 / 100
Momentum Score
Technically Bullish
73.0 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
14
1Yr Price target downside is -3%
6 analysts

36

S

3

W

3

O

2

T

SWOT Analysis

Aurinia Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..